LED Medical Reports Capital Raise, Improved Trading Volumes

Life Science Investing News

LED Medical Diagnostics Inc. (TSXV:LMD,OTCQX:LEDIF,FWB:LME) reported results from the first half of 2014: the Company raised $922,846 through the exercise of 4,035,811 warrants since January 1st, 2014, and trading volumes have improved significantly over the first six months of 2014, as compared to the same period for 2013.

LED Medical Diagnostics Inc. (TSXV:LMD,OTCQX:LEDIF,FWB:LME) reported results from the first half of 2014: the Company raised $922,846 through the exercise of 4,035,811 warrants since January 1st, 2014, and trading volumes have improved significantly over the first six months of 2014, as compared to the same period for 2013.

As quoted in the press release:

Trading volume in the U.S. on the OTCQX increased to 15,666,312 for the first six months of 2014, as compared to 359,300 common shares for the first six months of 2013. The company’s listing on the OTCQX in February 2013 was the initial step in the company’s strategy for raising its profile among U.S. institutions, analysts, stockbrokers and individual investors. Trading volume on the TSX.V was 38,600,981 for the first six months for 2014, as compared to 4,555,194 for the first six months of 2013. It is important to recognize much of the volume on the TSX.V is double counted via share delivery on the other exchanges. In Europe, trading primarily on the FSE was 2,154,673 for the first six months of 2014, as compared to 740,946 for the first six months of 2013.

Additionally, LED now has approval from the Depository Trust Company (“DTC”), which provides the company with DTC eligibility. DTC eligibility allows the Company shares to be easily and economically transferred between brokerage accounts electronically. The DTC is the largest securities depository in the world and acts like a clearinghouse for brokers. Through the DTC process, the Company can see the number of shares moving into US ownership hands; in the last 6 months well over 15% of the float have moved into US shareholders accounts.

LED Medical CEO, Dr. David Gane, said:

The company has undertaken a number of initiatives to increase its exposure and interest within the United States. Given that our corporate focus is on the U.S. diagnostic dental imaging market, the world’s largest by far, these undertakings just make sense.

Click here to read the LED Medical Diagnostics Inc. (TSXV:LMD,OTCQX:LEDIF,FWB:LME) press release
Click here to see the LED Medical Diagnostics Inc. (TSXV:LMD,OTCQX:LEDIF,FWB:LME) profile.

The Conversation (0)
×